Hyperthermic isolated limb perfusion with cisplatin in four patients with sarcomas of soft tissue and bone

European Journal of Surgical Oncology

Volumn 22, Issue 5, 1996, Pages 528-531

  Van Ginkel, Robert J ^a   Koops, Heimen Schraffordt ^a   De Vries, Elisabeth G E ^a   Molenaar, Willemina M ^a   Uges, Donald R A ^a   Hoekstra, Harald J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cisplatin; Hyperthermia; Malignant fibrous histiocytoma; Osteosarcoma; Perfusion; Sarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; MELPHALAN; TUMOR NECROSIS FACTOR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; EDEMA; ERYTHEMA; FEMALE; HUMAN; HYPERTHERMIC THERAPY; LIMB PERFUSION; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MOTOR NEUROPATHY; OSTEOSARCOMA; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; SENSORY NEUROPATHY; SOFT TISSUE SARCOMA; TEMPERATURE; TUMOR BIOPSY; TUMOR NECROSIS;

EID: 0029853522     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(96)93114-5     Document Type: Article

References (24)

1. Suit HD. Local control and patient survivral. Int J Radiat Oncol Biol Phys 1992; 23: 653-60.
2. Sadoski C, Suit HD, Rosenberg A, et al. Preoperative radiation, surgical margins, and local control of extremity sarcomas of soft tissues. J Surg Oncol 1993; 52: 223-30.
3. Eilber F, Giuliano A, Eckardt J, et al. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol 1987; 55: 21-6.
4. Casper ES, Gaynor JJ, Harrison LB. et al. Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade soft tissue sarcoma. Cancer 1994; 73: 1644-51.
5. Hoekstra HJ, Schraffordt Koops H, Molenaar WM, et al. Results of isolated regional perfusion in the treatment of malignant soft tissue tumors of the extremities. Cancer 1987; 60: 1703-7.
6. Rosenberg B, Van Camp L, Krigas T. Inhibition of cell division in Escherichia coli by electrolysis products from platinum electrode. Nature 1965; 205: 157-64.
7. De Vrics J, Hartel RM, Schraffordt Koops H, et al. Dosage of cisplatin in hyperthermic isolated regional perfusion. Surg Res Commun 1987; 2: 107-12.
8. van Ginkel RJ, Hoekstra HJ, Meutstege FJ, et al. Hyperthermic isolated regional perfusion with cisplatin in the local treatment of spontaneous canine osteosarcoma: assessment of short-term effects. J Surg Oncol 1995; 59: 169-76.
9. Creech O, Krementz ET, Ryan RF, et al Chemotherapy of cancer: regional perfusion utilizing an extra-corporeal circuit. Ann Surg 1958; 148: 616-32.
10. Fontijne WP, Mook PH, Schraffordt Koops H, et al. Improved tissue perfusion during pressure regulated regional perfusion: a clinical study. Cancer 1985; 55: 1455-61.
11. Wieberdink J, Benckhuysen C, Braat RP, et al. Dosimetry in isolated perfusion of the limb by assessment of perfused tissue voluem and grading of toxic tissue reactions. Eur J Cancer Clin Oncol 1982; 18: 905-10.
12. Hoekstra HJ, Naujocks T, Schraffordt Koops H, et al. Continuous leakage monitoring during hyperthermic isolated regional perfusion of the lower limb: techniques and results. Reg Cancer Treat 1992; 4: 301-4.
13. Coombs R, Halliday K. Biopsy techniques. In: Coombs R, Fricdlaender G (eds) Bone Tumour Management (1st edn). Cornwall: Robert Hartnoll Ltd, 1987: 81-7.
14. Guchelaar HJ, Hoekstra HJ, De Vries EGE, et al. Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities. Br J Cancer 1992; 65: 898-902.
15. Aigner K, Schwemmle K. Technic of isolated perfusion of the extremities. Experience with 171 cases. Langenbecks Arch Chir 1983; 359: 113-22.
16. Rosenberg B. Fundamental studies with cisplatin. Cancer 1985; 55: 2303-16.
17. Klein ES, Ben-Ari GY. Isolation perfusion with cisplalin for malignant melanoma of the limbs. Cancer 1987; 59: 1068-71.
18. Hoekstra JH, Schraffordt Koops H, De Vries EGE, et al. Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment. Cancer 1993; 72: 1224-9.
19. Ham SJ, Hoekstra HJ, van der Graaf WTA, et al. The value of high-dose methotrexate based (HD-MTX) neoadjuvant chemotherapy in malignant fibrous histiocytoma (MFH) of bone. J Clin Oncol 1996; 14: 790-6.
20. Fletcher WS, Pommier RF, Woltering EA, et al. Pharmacokinetics and results of dose escalation in cis-platin hyperthermic isolation limb perfusion. Ann Surg Oncol 1994; 1: 236-43.
21. van de Zee J, Broekmeyer-Reurink MP, van den Berg AP, et al. Temperature distribution and pH changes during hyperthermic regional isolation perfusion. Eur J Cancer Clin Oncol 1989; 25: 1157-63.
22. Vaglini M, Belli F, Santinami M. Isolation perfusion of the lower limb with platinum. World J Surg 1988; 12: 307-9.
23. Lienard D, Ewalenko P, Delmotte JJ, et al. High-dose recombinant tumour necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 1992; 10: 52-60.
24. Eggermont AMM, Lienard D, Schraffordt Koops H, et al. Limb salvage byhigh dose tumor necrosis factor alpha (TNF), gamma-interferon (IFN) and melphalan isolated limb perfusion (ILP) in patients with irresectable soft tissue sarcomas. Proc Am Soc Clin Oncol 1992; 11: 1444.